SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function

OBJECTIVE: Inhibition of the Na(+)-glucose cotransporter type 2 (SGLT2) is currently being pursued as an insulin-independent treatment for diabetes; however, the behavioral and metabolic consequences of SGLT2 deletion are unknown. Here, we used a SGLT2 knockout mouse to investigate the effect of inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurczak, Michael J., Lee, Hui-Young, Birkenfeld, Andreas L., Jornayvaz, Francois R., Frederick, David W., Pongratz, Rebecca L., Zhao, Xiaoxian, Moeckel, Gilbert W., Samuel, Varman T., Whaley, Jean M., Shulman, Gerald I., Kibbey, Richard G.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046850/
https://www.ncbi.nlm.nih.gov/pubmed/21357472
http://dx.doi.org/10.2337/db10-1328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046850/
https://www.ncbi.nlm.nih.gov/pubmed/21357472
http://dx.doi.org/10.2337/db10-1328

Ejemplares similares